Probiotic supplementation has little effect on peripheral blood regulatory T cells - 18/04/17
Doi : 10.1016/j.jaci.2016.06.055
Nicholas P. West, PhD a 
, Peggy L. Horn, PhD b, David B. Pyne, PhD b, Hilary S. Warren, PhD c, Suzanne Asad, BSc (Hons) d, Amanda J. Cox, PhD a, Sampo J. Lahtinen, PhD e, Markus J. Lehtinen, PhD e, Peter A. Fricker, MD b, Allan W. Cripps, PhD a, Barbara Fazekas de St Groth, PhD d
, Peggy L. Horn, PhD b, David B. Pyne, PhD b, Hilary S. Warren, PhD c, Suzanne Asad, BSc (Hons) d, Amanda J. Cox, PhD a, Sampo J. Lahtinen, PhD e, Markus J. Lehtinen, PhD e, Peter A. Fricker, MD b, Allan W. Cripps, PhD a, Barbara Fazekas de St Groth, PhD d a Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia
b Australian Institute of Sport, Canberra, Australia
c Cancer Immunology Research Unit, the Canberra Hospital, Canberra, Australia
d Centenary Institute and the Discipline of Dermatology, University of Sydney, Sydney, Australia
e DuPont Nutrition and Health, Kantvic, Finland
| The study was funded by Danisco Sweeteners Oy, now part of DuPont. This work was supported by the National Health and Medical Research Council (NHMRC) project grant 1012524. B.F.deSt.G. was supported by an NHMRC Principal Research Fellowship. |
|
| Disclosure of potential conflict of interest: N. P. West has received travel support from DuPont Health and Nutrition, has consultant arrangements with Probiotec Pty Ltd, and has received grants from the National Health and Medical Research Council (NHMRC). D. B. Pyne has received a grant and consulting honorarium from Danisco DuPont; has received payment for lectures from Sports Dietitians Australia; and has received travel support from the Australian Swimming Coaches Association. H. S. Warren has received grants from Griffith University. A. J. Cox has consultant arrangements with Probiotec Pty Ltd, and has received grants from the NHMRC. S. J. Lahtinen and M. J. Lehtinen are employed by DuPont Nutrition and Health. A. W. Cripps is the recipient of research funding from Danisco Sweeteners Oy, is a member of the Gold Coast Hospital Health Board; has consultant arrangements with Probiotec Pty Ltd, and has received grants from the NHMRC. B. F. de St. Groth is employed by the University of Sydney. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 138 - N° 6
P. 1749 - décembre 2016 Retour au numéro
Article précédent
- Mendelian randomization analysis demonstrates that low vitamin D is unlikely causative for pediatric asthma
- Erik B. Hysinger, Jeffrey D. Roizen, Frank D. Mentch, Lyam Vazquez, John J. Connolly, Jonathan P. Bradfield, Berta Almoguera, Patrick M. Sleiman, Julian L. Allen, Michael A. Levine, Hakon Hakonarson
- Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children
- Marie-Louise Frémond, Mathieu Paul Rodero, Nadia Jeremiah, Alexandre Belot, Eric Jeziorski, Darragh Duffy, Didier Bessis, Guilhem Cros, Gillian I. Rice, Bruno Charbit, Anne Hulin, Nihel Khoudour, Consuelo Modesto Caballero, Christine Bodemer, Monique Fabre, Laureline Berteloot, Muriel Le Bourgeois, Philippe Reix, Thierry Walzer, Despina Moshous, Stéphane Blanche, Alain Fischer, Brigitte Bader-Meunier, Fréderic Rieux-Laucat, Yanick Joseph Crow, Bénédicte Neven
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?